Synlogic (NASDAQ:SYBX) Stock Crosses Below Fifty Day Moving Average – Should You Sell?

Synlogic, Inc. (NASDAQ:SYBX)’s stock price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $1.42 and traded as low as $1.30. Synlogic shares last traded at $1.32, with a volume of 2,083 shares.

Synlogic Trading Down 2.6 %

The stock’s 50-day moving average is $1.42 and its 200-day moving average is $1.46. The stock has a market cap of $15.39 million, a price-to-earnings ratio of -0.32 and a beta of 0.81.

Synlogic (NASDAQ:SYBX) last released its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.17. On average, equities analysts predict that Synlogic, Inc. will post -2.71 earnings per share for the current fiscal year.

Synlogic Company Profile

Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.